Prokidney Corp.
PROK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850270
In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $99.5M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Prokidney Corp. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 69 | 56 | −13 |
| Shares | 48.0M | 35.2M | −12.8M (−26.6%) |
| Value | $42.0M | $20.9M | −$21.2M (−50.4%) |
New holders (20)
Institutions that held Prokidney Corp. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 591,688 | $350.3K | 0.00% |
| Gsa Capital Partners LLP | 510,615 | $302.0K | 0.02% |
| Marshall Wace, LLP | 464,812 | $274.2K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 351,622 | $208.2K | 0.01% |
| HRT Financial LP | 215,370 | $127.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 176,452 | $104.5K | 0.00% |
| Jain Global LLC | 112,406 | $66.6K | 0.00% |
| Two Sigma Investments, LP | 70,699 | $41.9K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 66,281 | $39.2K | 0.01% |
| Catalyst Funds Management Pty Ltd | 61,100 | $36.2K | 0.01% |
| Hudson Bay Capital Management LP | 29,887 | $17.7K | 0.00% |
| Ieq Capital, LLC | 23,051 | $13.6K | 0.00% |
| Jump Financial, LLC | 21,922 | $13.0K | 0.00% |
| Balyasny Asset Management LLC | 14,683 | $8.69K | 0.00% |
| ExodusPoint Capital Management, LP | 11,663 | $7.00K | 0.00% |
| Point72 (DIFC) Ltd | 9,200 | $5.45K | 0.00% |
| Skopos Labs, Inc. | 728 | $432 | 0.00% |
| Essential Partners LLC | 528 | $313 | 0.00% |
| Fortitude Family Office, LLC | 490 | $290 | 0.00% |
| US Bancorp | 200 | $118 | 0.00% |
Sold out (33)
Institutions that held Prokidney Corp. at the end of Q1 2025 and filed for Q2 2025 without it.